Methods |
Randomized controlled trial |
Participants |
214 subjects (19 died, 15 lost to follow‐up)
General Medicine Clinic (GMC):
58.7% Male
11.9% White
85.3% African‐American
Mean age: 35.0 +/‐ 8.2
Infectious Disease Clinic (IDC):
63.8% Male
20.0% White
71.4% African‐American
Mean age‐ 34.3% +‐ 9.0 |
Interventions |
CLINIC, HOSPITAL OR WARD VOLUME OF HIV/AIDS PATIENTS:
General Medicine Clinic staffed by internists ‐ <50 HIV patients
vs
Infectious Disease Clinic (staffed by ID specialists ‐ 1100 HIV patients) |
Outcomes |
PROPORTION OF PATIENTS ON ARVs:
GMC:
Use of 0 ‐ 20%
Use of 1 ‐ 47%
Use of 2 ‐ 20%
Use of 3 ‐ 13%
IDC:
Use of 0 ‐ 24%
Use of 1 ‐ 41%
Use of 2 ‐ 21%
Use of 3 ‐ 14%
PROPORTION OF PATIENTS ON INDICATED PROPHYLAXIS:
(MAC/PCP)
GMC:
MAC ‐ 66%
Appropriate PCP‐ 93%
IDC:
MAC ‐ 56%
Appropriate PCP ‐ 98%
HEALTHCARE UTLIZATION:
a) Visits to home clinic
GMC ‐ 4.31 visits
(+/‐ 3.81)
IDC ‐ 4.41 visits (+/‐ 4.69)
b) ER Visits
GMC ‐ 1.58 (+/‐ 3.03)
IDC ‐ 0.71 (+/‐ 1.49)
p=.01 (p<.05 after adjustment)
c) HOSPITALIZ‐
ATION
GMC ‐ 33%
IDC ‐ 25%
p=.11 (p=.08 after adjustment)
d) LENGTH OF HOSPITAL STAY
GMC ‐ 9 (+/‐ 7 days)
IDC ‐ 5.3 (+/‐ 3 days)p=.01 (p=.05 after adjustment)
PSYCHOSOCIAL OUTCOME: HRQL Scale (max score is 100)
a) physical
GMC
before 42.1 +/‐ 12.2
after ‐ 35.7 +/‐ 11.1
IDC
before 42.8 +/‐ 13.3
after 37.2 +/‐ 11.7
b) mental
GMC
before
42.4 +/‐ 12.5
after
37.8 +/‐ 11.8
IDC
before
40.2 +/‐ 12.7
after 37.2 +/‐ 11.7 |
Notes |
Difference btw healthcare utlization btw the two groups |
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Allocation concealment? |
Unclear risk |
D ‐ Not used |